We are live on
!
Find out more
Keros Therapeutics
KROS
KROS
81 hedge funds and large institutions have $1.13B invested in Keros Therapeutics in 2020 Q4 according to their latest regulatory filings, with 36 funds opening new positions, 34 increasing their positions, 6 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
800% more first-time investments, than exits
New positions opened: 36 | Existing positions closed: 4
467% more repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 6
148% more capital invested
Capital invested by funds: $454M → $1.13B (+$675M)
65% more funds holding
Funds holding: 49 → 81 (+32)
20.99% more ownership
Funds ownership: 58.41% → 79.39% (+21%)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
Holders
81
Holders Change
+32
Holders Change %
+65.31%
% of All Funds
1.43%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
36
Increased
34
Reduced
6
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$53.9M |
| 2 |
CCM
Consonance Capital Management
New York
|
+$35.1M |
| 3 |
BlackRock
New York
|
+$34.3M |
| 4 |
Alkeon Capital Management
New York
|
+$31M |
| 5 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$21.8M |
Top Sellers
| 1 |
LGM
Logos Global Management
San Francisco,
California
|
-$72.5M |
| 2 |
CA
CHI Advisors
New York
|
-$8.55M |
| 3 |
FI
Fosun International
Hong Kong,
China
|
-$3.22M |
| 4 |
TC
Telemus Capital
Southfield,
Michigan
|
-$775K |
| 5 |
Renaissance Technologies
New York
|
-$479K |
